BLOOD LACTATE DEHYDROGENASE INCREASED

This adverse event was reported 15861 times

These drugs are most commonly taken by patients reporting BLOOD LACTATE DEHYDROGENASE INCREASED:

# Drug Count
0 ECULIZUMAB 1589
1 PREDNISONE 1110
2 CYCLOPHOSPHAMIDE 1105
3 CYCLOPHOSPHAMIDE FOR INJECTION 1105
4 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 1105
5 RITUXIMAB 1046
6 PREDNISOLONE ORAL SOLUTION 835
7 PREDNISOLONE 834
8 PREDNISOLONE ORAL 834
9 DEXAMETHASONE 1.5 MG 784
See all common drugs associated with BLOOD LACTATE DEHYDROGENASE INCREASED

BLOOD LACTATE DEHYDROGENASE INCREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ONASEMNOGENE ABEPARVOVEC-XIOI 102 0.0442
1 POLATUZUMAB VEDOTIN 419 0.0411
2 METHYLENE BLUE 60 0.0380
3 ECULIZUMAB 1589 0.0292
4 VANCOMYCIN HYDROCHLORIDE 216 0.0258
5 BENDAMUSTINE HCL 377 0.0241
6 PEGCETACOPLAN 44 0.0232
7 BENDAMUSTINE HYDROCHLORIDE 182 0.0214
8 GEMTUZUMAB OZOGAMICIN 65 0.0177
9 GILTERITINIB 57 0.0140
See all drugs enriched for association with BLOOD LACTATE DEHYDROGENASE INCREASED

BLOOD LACTATE DEHYDROGENASE INCREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Complement Inhibitor [EPC] 1626 0.0289
1 CD33-directed Immunoconjugate [EPC] 65 0.0177
2 CD30-directed Immunoconjugate [EPC] 85 0.0082
3 Topoisomerase Inhibitor [EPC] 470 0.0061
4 Iron Chelator [EPC] 176 0.0060
5 Alkylating Drug [EPC] 1267 0.0052
6 Prostaglandin E1 Analog [EPC] 81 0.0049
7 Penem Antibacterial [EPC] 155 0.0045
8 Bile Acid [EPC] 101 0.0044
9 BCL-2 Inhibitor [EPC] 247 0.0039
See all drug classes enriched for association with BLOOD LACTATE DEHYDROGENASE INCREASED